No Data
No Data
TD Cowen Maintains Marinus Pharmaceuticals(MRNS.US) With Hold Rating
Marinus Pharmaceuticals GAAP EPS of -$0.42 In-line, Revenue of $8.54M Misses by $0.81M
Marinus Pharmaceuticals (MRNS) Reports Q3 Loss, Misses Revenue Estimates
Express News | Marinus Pharmaceuticals Inc Q3 Shr View $-0.41, Rev View $9.4 Mln -- LSEG IBES Data
Marinus Pharmaceuticals | 10-Q: Quarterly report
Marinus Pharmaceuticals Narrows 2024 Net Pdt Rev Guidance to $33M to $34M >MRNS
No Data
No Data